Why Diabetic Carb Control Can Be Like Walking A Tightrope
Anyone newly diagnosed with will soon find that while there is no cure, there are ways to keep this condition and its potential effects in check. Like a tightrope walker above a crowd, a diabetic must strive to strike a careful balance. In the diabetic's case, the balancing act involves blood sugar levels and food intake. Carbohydrate control is essential for maintaining the act.


Carbohydrates are found in many foods and are also considered important for a sound diet, even a diabetic's diet. With this in mind, diabetics often find themselves needing to learn carbohydrate control measures to ensure the intake doesn't exceed recommended amounts or cause them to fall off balance. The American Association recommends that carbohydrates, even for diabetics, account for about 50 to 60 percent of total daily caloric intake. What works for an individual diabetic, however, will go back to that balancing act. If that amount raises blood sugar levels too high, cutting back is likely in order.


Carbohydrates, which turn to glucose in the body, are found in a variety of foods; some are even a little surprising. To help diabetics get a handle on carbohydrate control, points systems, carb counting and even exchange programs have all been set up. What works for one diabetic might not be the best route for another to take. The key in carbohydrate control is to be able to identify the foods that have carbohydrates in the mix and learn to limit or avoid intake depending on how the tightrope walk is going at that moment in time.


The American Association has created its own version of the nutrition pyramid that really helps illustrate the continued importance of carbohydrates in a diabetic's diet. Drawn in the last and largest space of the pyramid, the bread, cereal, rice and pasta family is considered vital for daily nutrition. In a diabetic's case, however, healthier choices are necessary.


When looking to master carbohydrate control, the association's simple formula is helpful. It recommends between six and 11 servings from the grain group daily. The catch, however, comes in on the actual serving size. What people tend to eat as a serving and what a real serving actually is tend to be two very different things. For example, a single slice of bread, a quarter of an average size bagel, a half-cup of cooked cereal and third-cup of rice or pasta all qualify as single servings.


To exercise the tightest carbohydrate control possible, it is wise for diabetics to learn which foods contain carbs and what the correct serving sizes are for each item. When making choices about what to eat, it is also smart to go for healthier options. Whole grain breads, pasta and even rice are almost always better for a diabetic than processed choices. This isn't to say white bread, regular pasta or even a slice of cake can't be enjoyed once in a while. When the balancing act is kept in check, a little splurging now and again is generally just fine.


Some Basic Type Two Info

Diabetes Type Two info is provided here because sometimes accurate information is difficult to find. There are a number of sources for Type 2 diet info, but some of these are fad diets that may

Resveratrol - A Miracle Anti-Aging Drug Or Not?
Imagine a wonder drug that could slow down the aging process, and potentially one day provide a cure for disease such as diabetes and cancer. (Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire)
Amylin, Lilly And Alkermes Receive Complete Response Letter From FDA For Exenatide Once Weekly Submission
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding the New Drug Application (NDA) for BYDUREON? (exenatide for extended-release injectable suspension). In the complete response letter there are no requests for new pre-clinical or clinical trials... (Source: Health News from Medical News Today)
The Control Of Fatty Acid Uptake By Muscle Cells
A new study from the Swedish medical university Karolinska Institutet shows that the blood vessels and muscles of the heart can regulate the uptake of fatty acids that we ingest through meat, milk products and other food. The researchers behind the study have also identified the way in which regulation is governed by the muscles themselves. The results, which are published in the scientific journal Nature, open the way for new forms of treatment for pathological fat accumulation in the muscles which, in turn, increases the risk of type II (adult) diabetes and cardiovascular disease... (Source: Health News from Medical News Today)
FDA Requests Additional Information Regarding AFREZZA? In Complete Response Letter To MannKind
MannKind Corporation (Nasdaq:MNKD) announced that it has received a Complete Response letter from the U.S. Food & Drug Administration (FDA) regarding the New Drug Application (NDA) for AFREZZA? (insulin human [rDNA origin]) Inhalation Powder for the treatment of adult patients with type 1 and type 2 diabetes mellitus for the control of hyperglycemia. A Complete Response letter is issued by the FDA's Center for Drug Evaluation and Research when the review of a file is completed and questions remain that preclude the approval of the NDA in its current form... (Source: Health News from Medical News Today)
Minorities At Greater Risk For Kidney Disease
Certain ethnic minorities, including African Americans and Hispanics, are at a higher risk than the general population for developing potentially life-threatening chronic kidney disease (CKD) , which has been linked to higher rates of diabetes and high blood pressure, according to the National Kidney Foundation (NKF)... (Source: Health News from Medical News Today)
Publix Pharmacies Launch Free Metformin For Type II Diabetes Patients As New Diabetes Program Debuts
Publix Pharmacies launched the first phase of a new diabetes management system. The program is a multi-faceted program established to assist customers and associates living with diabetes in managing their medication, compliance, monitoring, education, nutrition and exercise. In its first phase, this one-of-a-kind program offers diabetic patients free medication, online resources and the benefit of knowledgeable pharmacists. At the core of the program is the free generic immediate-release metformin (500 mg, 850 mg or 1,000 mg) - the generic form of the drug Glucophage... (Source: Health News from Medical News Today)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Prevalence of the Metabolic Syndrome among rural original adults in NingXia, China
Background Metabolic syndrome (MS) is combination of medical disorders that increase people's risk for cardiovascular disease and diabetes mellitus. Little data exists on the prevalence of MS of rural original adults in Ningxia of China.Methods A cross-sectional survey method was used and the participants were interviewed by trained health workers under a structured questionnaire in rural of Ningxia in 2008. The number of research subjects was 1612. MS was defined by International Diabetes Federation IDF (2005).Results The age-adjusted prevalence of the metabolic syndrome was 11.8%, whereas ethnic-specific prevalence was 10.3% in Han ethnic group and 13.7% in Hui ethnic group. Components of MS and MS were more common in Hui ethnic group than Han ethnic group. The mean levels and prevalence...
Program opens girls&#8217; eyes to science
After Keisha Barreto saw many of her relatives suffer serious health issues, she knew she wanted to be a doctor. "My mother has diabetes, my uncle died from heart problems and there is cancer in my family," said Barreto, a high school junior. "If there's... (Source: OrlandoSentinel: Medical Research)
Association between physical activity and metabolic syndrome: a cross sectional survey in adolescents in Ho Chi Minh City, Vietnam
Conclusions: A more physically active lifestyle appears to be associated with a lower odds of metabolic syndrome in Vietnamese adolescents. Socio-economic status should be taken into account when planning interventions to prevent adolescent metabolic syndrome. (Source: BMC Public Health - Latest articles)
Sernova Announces Interim Results From Key Preclincal Study With Its Proprietary Cell Pouch SystemTM
Sernova Corp. (TSX VENTURE:SVA) today reported interim results from a key porcine diabetes study evaluating the safety and efficacy of the Cell Pouch System?. Interim results, to be presented at the American Society of Artificial Internal Organs 56th Annual Conference, Baltimore, MD, May 27th-29th in a podium presentation, confirm that the Cell Pouch System? establishes a biological environment capable of preserving the functionality of therapeutic cells... (Source: Health News from Medical News Today)
PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid &#x03C9;-Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver Disease
Fatty liver disease is a common lipid metabolism disorder influenced by the combination of individual genetic makeup, drug exposure, and life-style choices that are frequently associated with metabolic syndrome, which encompasses obesity, dyslipidemia, hypertension, hypertriglyceridemia, and insulin resistant diabetes. Common to obesity related dyslipidemia is the excessive storage of hepatic fatty acids (steatosis), due to a decrease in mitochondria &#x03B2;-oxidation with an increase in both peroxisomal &#x03B2;-oxidation, and microsomal &#x03C9;-oxidation of fatty acids through peroxisome proliferator activated receptors (PPARs). How steatosis increases PPAR&#x03B1; activated gene expression of fatty acid transport proteins, peroxisomal and mitochondrial fatty acid &#x03B2;-oxidation an...<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Old Arthritis Drug May Help Diabetics (CME/CE)
A drug widely used to treat joint pain improved blood glucose control in patients with type 2 diabetes, researchers said. (Source: MedPage Today Nephrology)
Type 2 Diabetes Study: Drugs Don't Cut Heart Disease Risk
New data suggest that aggressive drug treatments to reduce known heart-disease risk factors don't actually help Type 2 diabetes patients. Why? And what now? (Source: TIME.com: Top Science and Health Stories)
Globe article on the cost of care at Children?s
A Boston Globe article this morning brought the cost of care here at Children?s Hospital Boston into question, saying, among other things, that ?Children?s charges the highest fees for both outpatient and inpatient care.? It?s based on data by Harvard Pilgrim Health Care (HPHC) that we don?t feel accurately reflects the care that we provide. While the writer, Liz Kowalczyk, did say that because about 30 percent of our patients are on Medicaid, we have to ?make up the lost revenue from private insurers,? I don?t think she went far enough in explaining why our costs tend to be higher than other hospitals in the state. First and most important, Children?s is the only freestanding children?s hospital on the Globe?s list, so comparing the care we deliver to that of hospi...
Valsartan delays progression to type 2 diabetes
Results from a landmark study involving more than 9,000 people showed that the high blood pressure medicine valsartan delayed progression to type 2 diabetes in patients with cardiovascular disease or risk factors and impaired glucose tolerance (IGT). (Source: Pharmacy Europe)
Obesity and lung inflammation
The prevalence of obesity has increased dramatically worldwide, predisposing individuals to an increased risk of morbidity and mortality due to cardiovascular disease and type 2 diabetes. Less recognized is the fact that obesity may play a significant role in the pathogenesis of pulmonary diseases through mechanisms that may involve proinflammatory mediators produced in adipose tissue that contribute to a low-grade state of systemic inflammation. In animal models, inflammatory responses in the lung have been shown to influence the production of the adipocytokines, leptin and adiponectin, cytokines, acute phase proteins, and other mediators produced by adipose tissue that may participate in immune responses of the lung. An increased adipose tissue mass may also influence susceptibility to p...<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
BES: Testosterone Gel Improves Diabetes in Hypogonadal Men (CME/CE)
MANCHESTER, England (MedPage Today) -- Topical testosterone replacement reduced insulin resistance and glycated hemoglobin in men who were deficient in the hormone and at risk for, or diagnosed with type 2 diabetes, researchers reported here. (Source: MedPage Today Cardiovascular)
Generex Oral-lyn(TM) Presentation at CODHy Congress
WORCESTER, Mass., March 16, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that Philip Raskin, MD, of The University of Texas Southwestern Medical Center in Dallas, Texas, made a presentation in respect of Generex Oral-lyn(tm), the Company's proprietary buccal insulin spray product, at The Latin America Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy) held in Buenos Aires, Argentina, March 11-14, 2010 (www.comtecmed.com/Codhy/argentina). (Source: Medical News (via PRIMEZONE))
New Research Reveals Potential New Drug For Type 2 Diabetes
An experimental oral drug has lowered blood sugar levels and inflammation in mice with Type 2 diabetes, suggesting that the medication could someday be added to the arsenal of drugs used by millions of Americans with this disease, according to new research. The drug consists of a synthetic molecule that stops the biological activity of a protein called macrophage migration inhibitory factor, or MIF. This protein is implicated in a number of diseases because it is associated with the production of inflammation in the body... (Source: Health News from Medical News Today)
More Support For Health Benefits Of Coffee
Multitudes of people worldwide begin each day with a cup of steaming hot coffee. Although it is sometimes referred to as "the devil's brew," coffee contains several nutrients (eg, calcium) as well as hundreds of potentially biologically active compounds (eg, polyphenols) that may promote health. For instance, observational studies have suggested a beneficial link between coffee consumption and type 2 diabetes. Determining whether or not this association is causative, however, requires controlled intervention trials... (Source: Health News from Medical News Today)
New Research Reveals Potential New Drug For Type 2 Diabetes
An experimental oral drug has lowered blood sugar levels and inflammation in mice with Type 2 diabetes, suggesting that the medication could someday be added to the arsenal of drugs used by millions of Americans with this disease, according to new research... (Source: Biology / Biochemistry News From Medical News Today)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Diabetes Trial: Drug Treatment May Not Cut Heart Disease
New data suggest that aggressive drug treatments to reduce known heart-disease risk factors don't actually help diabetes patients. Why? And what now? (Source: TIME.com: Top Science and Health Stories)
Diabetes' link to eating disorders explored
Diabetics, under the gun to better manage their disease by controlling their food intake and weight, may find themselves in the sticky wicket of needing treatment that makes them hungry, researchers said. (Source: ScienceDaily Headlines)
Partners reducing effects of diabetes (PREDICT): a diabetes prevention physical activity and dietary intervention through African-American churches
Type 2 diabetes is epidemic in the United States with greater incidence rates in African-American communities. Lifestyle interventions during the phase of insulin resistance mitigate cardiovascular risk and prevent diabetes. The primary aim of this study is to test the impact of a Community Health Advisor (CHA)-based diabetes prevention controlled intervention in urban African-American communities. In this controlled trial, church congregants in New Haven, CT, receiving a 1-year CHA-led diabetes prevention intervention were compared with church congregants in Bridgeport, CT, who did not receive an intervention. Outcome measures included physical activity, dietary pattern, anthropometric measure, social support, diabetes knowledge, nutrition and exercise self-efficacy. The results indicate ...
The role of collective efficacy in exercise adherence: a qualitative study of spousal support and Type 2 diabetes management
Adhering to increased exercise is often reported as one of the greatest challenges facing adults living with diabetes, a perception shared by the married middle-aged and older adults living with diabetes who participated in this study. Understanding how that challenge can best be met is both research and program relevant. Drawing on the social cognitive theory and social support literature, this qualitative study explored the powerful couple relationship in Type 2 diabetes management. The overarching goal of this paper was to illuminate the potentially key role of collective efficacy in exercise adherence in order to develop and test interventions that provide more effective supports for adults living with diabetes. Analyses revealed three core themes used by the couples to describe their ...
Lifestyle And Diet Still Best Ways To Help Prevent Type 2 Diabetes
Researchers looking at whether using a drug that lowers blood pressure (Valsartan) or a drug that lowers blood glucose levels (Nateglinide) could prevent Type 2 diabetes from developing found no great difference in the number of people who went on to develop the condition when prescribed either drug compared with the people who were prescribed a dummy pill. The drugs were also not successful in preventing heart attacks and strokes, which are complications of Type 2 diabetes. All the people taking part in the study had high blood glucose levels... (Source: Health News from Medical News Today)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Study Shows Superior Efficacy For TAXUS(R) Express(R) Stents At One Year Compared To Bare-Metal Stents In Diabetic Patients Experiencing Heart Attack
Boston Scientific Corporation (NYSE: BSX) announced results from an analysis of one-year subset data from the HORIZONS AMI trial assessing the impact of diabetes on clinical and angiographic outcomes in heart attack patients treated with the TAXUS® Express2? Paclitaxel-Eluting Stent System or the Express® bare-metal stent... (Source: Health News from Medical News Today)
Generic Drug For Type 2 Diabetes Passes Next Clinical Hurdle
Clinical studies of a generic drug called salsalate, widely prescribed for arthritis, now provide early promising results that it may be useful for the treatment of patients with type 2 diabetes as well. Salsalate is an atypical non-steroidal anti-inflammatory agent that is chemically similar to aspirin but a bit easier on the stomach. In a three-month trial of people with type 2 diabetes that was led by Joslin Diabetes Center researchers, those who took the drug showed significantly improved blood glucose levels... (Source: Health News from Medical News Today)
Lifestyle And Diet Still Best Ways To Help Prevent Type 2 Diabetes
Researchers looking at whether using a drug that lowers blood pressure (Valsartan) or a drug that lowers blood glucose levels (Nateglinide) could prevent Type 2 diabetes from developing found no great difference in the number of people who went on to develop the condition when prescribed either drug compared with the people who were prescribed a dummy pill... (Source: Diabetes News From Medical News Today)
Study Shows Superior Efficacy For TAXUS(R) Express(R) Stents At One Year Compared To Bare-Metal Stents In Diabetic Patients Experiencing Heart Attack
Boston Scientific Corporation (NYSE: BSX) announced results from an analysis of one-year subset data from the HORIZONS AMI trial assessing the impact of diabetes on clinical and angiographic outcomes in heart attack patients treated with the TAXUS® Express2? Paclitaxel-Eluting Stent System or the Express® bare-metal stent... (Source: Diabetes News From Medical News Today)
Generic Drug For Type 2 Diabetes Passes Next Clinical Hurdle
Clinical studies of a generic drug called salsalate, widely prescribed for arthritis, now provide early promising results that it may be useful for the treatment of patients with type 2 diabetes as well. Salsalate is an atypical non-steroidal anti-inflammatory agent that is chemically similar to aspirin but a bit easier on the stomach... (Source: Diabetes News From Medical News Today)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Researcher urges caution in reducing blood pressure
For patients with diabetes and heart disease, less isn't always more &#8212; at least when it comes to blood pressure. New data show an increased risk of heart attack, stroke or death for patients having blood pressure deemed too high &#8212; or too low,... (Source: OrlandoSentinel: Medical Research)
UNC's Dr. John Buse To Receive National Award For Clinical Excellence
John B. Buse, M.D., Ph.D., has been selected to receive a Clinical Excellence award at the Castle Connolly National Physician of the Year Awards ceremony. Buse is a professor in the University of North Carolina at Chapel Hill School of Medicine, chief of the division of endocrinology and metabolism and director of the UNC Diabetes Care Center... (Source: Health News from Medical News Today)
Mayo Clinic Proceedings Study Finds Link Between Hypoglycemia And Mortality Rates In Critically Ill
In a study published in the March issue of Mayo Clinic Proceedings, researchers report that they have found a link between mild to moderate hypoglycemia (low blood sugar) and mortality in critically ill patients. The multicenter study involved six medical centers from Australia, New Zealand and Japan. The purpose of the study was to understand the epidemiology, severity, duration, recovery and outcome associations of hypoglycemia in critically ill patients... (Source: Health News from Medical News Today)
Mayo Clinic Proceedings Study Finds Link Between Hypoglycemia And Mortality Rates In Critically Ill
In a study published in the March issue of Mayo Clinic Proceedings, researchers report that they have found a link between mild to moderate hypoglycemia (low blood sugar) and mortality in critically ill patients. The multicenter study involved six medical centers from Australia, New Zealand and Japan... (Source: Diabetes News From Medical News Today)
UNC's Dr. John Buse To Receive National Award For Clinical Excellence
John B. Buse, M.D., Ph.D., has been selected to receive a Clinical Excellence award at the Castle Connolly National Physician of the Year Awards ceremony. Buse is a professor in the University of North Carolina at Chapel Hill School of Medicine, chief of the division of endocrinology and metabolism and director of the UNC Diabetes Care Center... (Source: Public Health News From Medical News Today)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Vital Signs: Study Links Soda Price Increases to Better Health
Research found that when the price of a two-liter bottle went up, people consumed less, which was associated with a drop in weight and a lower risk for pre-diabetes. (Source: NYT)
Landmark ACCORD Trial Finds Intensive Blood Pressure and Combination Lipid Therapies do not Reduce Combined Cardiovascular Events in Adults with Diabetes
Source: National Heart, Lung, and Blood Institute - Related MedlinePlus Page: Diabetes Complications (Source: MedlinePlus Health News)
Socio-economic differences in life expectancy among persons with diabetes mellitus or myocardial infarction: results from the German MONICA/KORA study
Conclusion: This study shows that in Germany the differences in LE by socio-economic status are comparable to those found in other European countries, and that these differences seem to increase when diabetes mellitus or myocardial infarction are present. The statistical method used allows estimates of LE with relatively small datasets. (Source: BMC Public Health - Latest articles)
No benefit of lower blood pressure or lipid targets in type 2 diabetes
Read the full story on MD Consult: No benefit of lower blood pressure or lipid targets in type 2 diabetes (Source: MD Consult: News: Top Stories)
Drugs in type 2 diabetes: their properties and recommended use
There are now six classes of oral antidiabetic drugs and a new class of injectable GLP-1 agonists in the drug therapy of type 2 diabetes, with metformin remaining the cornerstone of treatment. Our Drug review considers their mode of action, properties and recommended use, followed by sources of further information and an analysis of prescription data. Copyright © 2010 Wiley Interface Ltd (Source: Prescriber)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Pluripotent plasticity of stem cells and liver repopulation
Different types of stem cells have a role in liver regeneration or fibrous repair during and after several liver diseases. Otherwise, the origin of hepatic and/or extra-hepatic stem cells in reactive liver repopulation is under controversy. The ability of the human body to self-repair and replace the cells and tissues of some organs is often evident. It has been estimated that complete renewal of liver tissue takes place in about a year. Replacement of lost liver tissues is accomplished by proliferation of mature hepatocytes, hepatic oval stem cells differentiation, and sinusoidal cells as support. Hepatic oval cells display a distinct phenotype and have been shown to be a bipotential progenitor of two types of epithelial cells found in the liver, hepatocytes, and bile ductular cells. In g...
Salsalate May Help Treat Type 2 Diabetes
Salsalate, a common pain reliever, may help people with type 2 diabetes control their blood sugar levels. (Source: WebMD Health)
Observatory: Seeking Safe Ways to Deliver Nitric Oxide in Medical Care
Researchers are investigating new methods for storing and releasing an important gas for those who do not produce enough of it. (Source: NYT &gt; Health)
To Cut Diabetes Heart Risks, Diet and Exercise May Beat Drugs
A 5-step action plan for lowering heart risks associated with diabetes. (Source: U.S. News - Health)
Salsalate As a Type 2 Diabetes Treatment? It Looks Promising
A longtime arthritis medicine could one day be an affordable diabetes treatment. (Source: U.S. News - Health)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Drug Helps Diabetics, Trial Finds
A generic anti-inflammatory drug from the aspirin family helped patients in a clinical trial lower their blood sugar. (Source: NYT &gt; Health)
Arthritis Drug May Fight Diabetes, Too
Study finds that salsalate helps control blood sugar levels Source: HealthDay Related MedlinePlus Pages: Arthritis, Diabetes, Medicines (Source: MedlinePlus Health News)
Adding fat-lowering drug no help for diabetic hearts
ATLANTA (Reuters) - Adding a drug that lowers blood fats known as triglycerides to cholesterol-fighting statins provided no additional protection from heart attack, stroke and death from heart disease in patients with Type 2 diabetes, according to data from a large study. (Source: Reuters: Health)
Boosting Vitamin D Can Do a Heart Good
In those with low levels to start, odds eased for diabetes, cardio woes, study found Source: HealthDay Related MedlinePlus Pages: Heart Diseases--Prevention, Vitamin D (Source: MedlinePlus Health News)
Vital Signs: Study Links Soda Price Increases to Better Health
Research found that when the price of a two-liter bottle went up, people consumed less, which was associated with a drop in weight and a lower risk for pre-diabetes. (Source: NYT &gt; Health)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Adding Fat-Lowering Drug No Help for Diabetic Hearts
Adding a drug that lowers blood fats known as triglycerides to cholesterol-fighting statins provided no additional protection from heart attack, stroke and death from heart disease in patients with Type 2 diabetes, according to data from a large study.Source: Reuters Health Related MedlinePlus Pages: Diabetes, Heart Diseases, Statins (Source: MedlinePlus Health News)
Ezetimibe Reduces Hepatic Fat in Obese Patients
In insulin-resistant subjects on a weight loss diet, ezetimibe (Zetia) reduces hepatic steatosis and inflammatory markers, Australian researchers report in the February 25th online issue of Diabetes Care. Reuters Health Information (Source: Medscape Diabetes Headlines)
Exenatide Improves Postprandial Endothelial Function
The diabetes drug exenatide (Byetta) is known to lower glucose and is believed to lower lipid excursions after meals, but new research suggests that it may also improve endothelial function. Reuters Health Information (Source: Medscape Diabetes Headlines)
ACC: Saline, Bicarb Tie for Kidney Safety (CME/CE)
ATLANTA (MedPage Today) -- Sodium bicarbonate hydration appears no better than the old standard, saline, in preventing kidney damage from use of radiology contrast agents in at-risk diabetes patients, according to one of the first head-to-head comparison trials. (Source: MedPage Today Cardiovascular)
Alkermes shares pop on FDA's diabetes-drug response
Alkermes Inc. shares popped Monday on news that federal regulators responded positively to a new diabetes-drug application filed by the Waltham, Mass.-based biotechnology firm and its development partners, Amylin Pharmaceuticals Inc. and Eli Lilly and Co. (LLY) (Source: bizjournals.com Health Care:Biotechnology headlines)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Publix launches new diabetes program
Publix Pharmacies launched the first phase of a new diabetes management system March 15, which offers diabetic patients free medication. (Source: bizjournals.com Health Care:Biotechnology headlines)
NGM closes 1st tranche of $51M round
NGM Biopharmaceuticals closed the first tranche of a $51 million Series B financing, with plans to funnel the cash into diabetes treatments. (Source: bizjournals.com Health Care:Biotechnology headlines)
ACCORD lipid: Fibrates do not improve CV outcomes in diabetic patients taking statins
Combination therapy with fenofibrate and simvastatin does not provide additional protection against cardiovascular disease in high-risk patients with Type 2 diabetes compared with simvastatin alone, according to findings from the ACCORD lipid trial. (Source: MedWire News - Lipidology)
Novel therapeutic concepts * The epidemic of cardiovascular disease in the developing world: global implications
The epidemic of cardiovascular disease (CVD) is a global phenomenon, and the magnitude of its increase in incidence and prevalence in low- and middle-income countries (LIMIC) has potentially major implications for those high-income countries that characterize much of the developed world. Cardiovascular disease remains the leading cause of death in the world and approximately 80% of all cardiovascular-related deaths occur in LIMIC and at a younger age in comparison to high-income countries. The economic impact in regard to loss of productive years of life and the need to divert scarce resources to tertiary care is substantial. The &lsquo;epidemiologic transition&rsquo; provides a useful framework for understanding changes in the patterns of disease as a result of societal and socioeconomic ...
Comparison of health-related measures of two groups of adolescents in a rural southeastern county in the United States
Conclusion Thus, this research shows differences between similar populations in the same county and these differences must be explored further. (Source: Health Education Journal)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Behavioural change in type 1 diabetes self-management: Why and how?
Conclusions Individuals intensively self-managing their diabetes have a high degree of motivation to improve glycaemic control, but also require the assistance of health professionals in primary and secondary care to enable this to take place. (Source: Health Education Journal)
Body's anticipation of a meal can be a diabetes risk factor
Alterations in our response to the taste or smell of food may be another culprit responsible for Type 2 diabetes, according to scientists who have identified the specific mechanism in human specimens and in mice. (Source: ScienceDaily Headlines)
Search for Better Diabetes Therapy Falls Short
New strategies to prevent and treat diabetes and heart disease failed to improve care in two major studies, frustrating researchers' efforts to find more-effective approaches to the world's burgeoning diabetes epidemic. (Source: RWJF News Digest - Quality/Equality)
Rhythm Pharma launches, raises $21M
Rhythm Pharmaceuticals Inc., a developer of peptide-based drugs to treat conditions such as obesity and diabetes, has launched with a $21 million Series A round of funding. The round was led by Boston?s MPM Capital and New Enterprise Associates of Maryland. (Source: bizjournals.com Health Care:Biotechnology headlines)
Landmark Accord Trial Finds Intensive Blood Pressure and Combination Lipid Therapies do not Reduce Combined Cardiovascular Events in Adults with Diabetes
BETHESDA, Md.,&nbsp;March 15, 2010--&nbsp;Lowering blood pressure to normal levels - below currently recommended levels - did not significantly reduce the combined risk of fatal or nonfatal cardiovascular disease events in adults with type 2... (Source: Drugs.com - Clinical Trials)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
FDA letter moves Amylin drug toward approval
Amylin Pharmaceuticals, and partners Eli Lilly & Co. and Alkermes Inc., said Monday that their exenatide diabetes treatment is moving closer to approval by the Food and Drug Administration. (AMLN) (LLY) (Source: bizjournals.com Health Care:Biotechnology headlines)
Academia is still not doing enough to make UK a leader in research
(Source: BMJ Online First)
Diabetes Drug From Lilly, Amylin Under Scrutiny
FDA asks for more detail on labeling of Bydureon, pharmaceutical firms' shares show little impact. (Source: PharmaManufacturing.com)
ACCORD lipid: Fibrates do not improve CV outcomes in diabetic patients taking statins
Combination therapy with fenofibrate and simvastatin does not provide additional protection against cardiovascular disease in high-risk patients with Type 2 diabetes compared with simvastatin alone, according to findings from the ACCORD lipid trial. (Source: MedWire News - Diabetes)
Landmark ACCORD Trial Finds Intensive Blood Pressure and Combination Lipid Therapies do not Reduce Combined Cardiovascular Events in Adults with Diabetes
Lowering blood pressure to normal levels -- below currently recommended levels -- did not significantly reduce the combined risk of fatal or nonfatal cardiovascular disease events in adults with type 2 diabetes who were at especially high risk for cardiovascular disease events, according to new results from the landmark Action to Control Cardiovascular Risk in Diabetes (ACCORD) clinical trial. Similarly, treating multiple blood lipids with combination drug therapy of a fibrate and a statin did not reduce the combined risk of cardiovascular disease events more than treatment with statin alone. The study of more than 10,000 participants is sponsored by the National Institutes of Health. (Source: National Institutes of Health (NIH) News Releases)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Blood Pressure Drugs No Help for Diabetes
Studies: Statins, Fibrates to Lower Fats, Cholesterol and Blood Pressure Do Not Reduce Heart Attack Risk in Diabetics (Source: Health News: CBSNews.com)
ACCORD BP: Intensive BP control does not benefit diabetic patients at high CV risk
Intensive blood pressure control does not reduce the rate of cardiovascular events in patients with Type 2 diabetes and high CV risk, reveals research presented at the 59th Annual Scientific Sessions of the American College of Cardiology in Atlanta, Georgia, USA. (Source: MedWire News - Hypertension)
ACCORD lipid: Fibrates do not improve CV outcomes in diabetic patients taking statins
Combination therapy with fenofibrate and simvastatin does not provide additional protection against cardiovascular disease in high-risk patients with Type 2 diabetes compared with simvastatin alone, according to findings from the ACCORD lipid trial. (Source: MedWire News - Cardiology)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Nateglinide, Valsartan Have Little Effect on Preventing Diabetes or Cardiovascular Events
(Source: Physician's First Watch current issue)
FDA Asks for Risk Plan Info on Diabetes Drug
From Associated Press (March 15, 2010) SAN DIEGO -- Amylin Pharmaceuticals Inc. said Monday it received a Food and Drug Administration request for information on manufacturing and a risk mitigation plan for a potential once-weekly diabetes... (Source: Drugs.com - Pharma News)
Novartis International AG (CH) - NAVIGATOR Shows valsartan Delayed Progression to type 2 diabetes in at-risk Cardiovascular Patients with Impaired Glucose Tolerance
*NAVIGATOR study involved more than 9,000 patients, making it one of the largest and longest global trials to date in pre-diabetic patients * Valsartan-based regimen reduced risk of developing new-onset diabetes by 14%, but did not reduce risk... (Source: Drugs.com - Clinical Trials)
Drugs for halting diabetes tested
Conclusion Overall, this large, industry-funded study found that nateglinide had no effect on the incidence of diabetes or cardiovascular disease in this population and that valsartan had a small effect on diabetes risk but not on cardiovascular outcomes. This was well-conducted research and used the most robust study design for comparing the effectiveness of one treatment with another. There are some points to highlight, including the fact that 20% of participants in each trial arm dropped out of the study (they either withdrew their participation, died or were lost in the follow-up). Other important points relating to the research and its interpretation are raised in an accompanying editorial in the journal, written by Dr. David Nathan from the Diabetes Centre at Harvard Medical School. ...
Enhancing Excellence in Endocrinology (E3) ? Senior Leaders
Enhancing Excellence in Endocrinology (E3) is delighted to announce that registration is now open for the next advanced communications and management skills training course &#8211; Senior Leaders &#8211; which will be held on 14&#8211;15 October 2010 at the University of Warwick Conference Centre. Designed for consultants in adult or paediatric endocrinology who have been in their consultant post for at least 5 years, this 2-day bespoke high level training experience is delivered by leading professionals and communication and business skills trainers. The course will address the challenges you may face in your senior role allowing you to: enhance your leadership and organisational development skills; have a better understanding of your team and core communication skills; enhance your busi...<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Abbott Statement: ACCORD Lipid Results Support Treatment Guidelines for Fibrate Use
&nbsp; ATLANTA, March 14 /PRNewswire-FirstCall/ -- Results were presented today on behalf of the National Heart, Lung and Blood Institute from ACCORD, a study in patients with diabetes that evaluated cardiovascular outcomes in three distinct studies... (Source: Drugs.com - Clinical Trials)
Diabetes drugs 'ineffective'
Tests on two Novartis-made diabetes drugs have concluded that both have little or no effect on the condition, it has been revealed. (Source: Nursing Times Breaking News)
Hormonal Therapy and Sex Reassignment: A Systematic Review and Meta-analysis of Quality of Life and Psychosocial Outcomes
What is the prognosis of individuals with gender identity disorder receiving hormonal therapy as a part of sex reassignment, in terms of quality of life and other self-reported psychosocial outcomes? Clinical Endocrinology (Source: Medscape Today Headlines)
Abbott Statement: ACCORD Lipid Results Support Treatment Guidelines For Fibrate Use
Results were presented today on behalf of the National Heart, Lung and Blood Institute from ACCORD, a study in patients with diabetes that evaluated cardiovascular outcomes in three distinct studies - glycemic control, blood pressure control and lipid control... (Source: Cardiovascular / Cardiology News From Medical News Today)
Abbott Statement: ACCORD Lipid Results Support Treatment Guidelines For Fibrate Use
Results were presented today on behalf of the National Heart, Lung and Blood Institute from ACCORD, a study in patients with diabetes that evaluated cardiovascular outcomes in three distinct studies - glycemic control, blood pressure control and lipid control. In response to data from the ACCORD Lipid study, Abbott issued the following statement: "The results of ACCORD Lipid were widely expected and not surprising given that two-thirds of patients in the trial would not be treated with fibrates under current guidelines," said Eugene Sun, M.D... (Source: Health News from Medical News Today)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Intensive BP, Combined Lipid Therapies Do Not Help Adults With Diabetes
Lowering blood pressure to normal levels - below currently recommended levels - did not significantly reduce the combined risk of fatal or nonfatal cardiovascular disease events in adults with type 2 diabetes who were at especially high risk for cardiovascular disease events, according to new results from the landmark Action to Control Cardiovascular Risk in Diabetes (ACCORD) clinical trial. Similarly, treating multiple blood lipids with combination drug therapy of a fibrate and a statin did not reduce the combined risk of cardiovascular disease events more than treatment with statin alone... (Source: Health News from Medical News Today)
More Adequate Provision Of Eye Care Services Need To 'Close The Gap' In Vision Loss In Indigenous People, Australia
Blindness rates in Indigenous Australians are still much higher than in non-Indigenous Australians, despite a probable fall in overall rates of blindness in Indigenous people in the past 30 years, according to research published in the Medical Journal of Australia. Most blindness was due to readily preventable or treatable causes of vision loss, including cataract, diabetes, refractive error and trachoma... (Source: Health News from Medical News Today)
Intensive BP, Combined Lipid Therapies Do Not Help Adults With Diabetes
Lowering blood pressure to normal levels - below currently recommended levels - did not significantly reduce the combined risk of fatal or nonfatal cardiovascular disease events in adults with type 2 diabetes who were at especially high risk for cardiovascular disease events, according to new results from the landmark Action to Control Cardiovascular Risk in Diabetes (ACCORD) clinical trial... (Source: Hypertension News From Medical News Today)
Exercising Just Got Easier For Busy People, Study Shows
If you're the type of person who invokes the "not enough time" clause when it comes to exercising, it's time to find a new excuse. Researchers who have been studying interval training have found that it not only takes less time than what is typically recommended, but the regimen does not have to be "all out" to be effective in helping reduce the risk of such diseases at Type 2 diabetes. The study appears in the March issue of The Journal of Physiology... (Source: Health News from Medical News Today)
Exercising Just Got Easier For Busy People, Study Shows
If you're the type of person who invokes the "not enough time" clause when it comes to exercising, it's time to find a new excuse. Researchers who have been studying interval training have found that it not only takes less time than what is typically recommended, but the regimen does not have to be "all out" to be effective in helping reduce the risk of such diseases at Type 2 diabetes... (Source: Diabetes News From Medical News Today)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
2 Drugs Fail to Prevent Diabetes in the Overweight
Title: 2 Drugs Fail to Prevent Diabetes in the OverweightCategory: Health NewsCreated: 3/14/2010 10:10:00 AMLast Editorial Review: 3/15/2010 (Source: MedicineNet Cholesterol General)
2 Drugs Fail to Prevent Diabetes in the Overweight
Title: 2 Drugs Fail to Prevent Diabetes in the OverweightCategory: Health NewsCreated: 3/14/2010 10:10:00 AMLast Editorial Review: 3/15/2010 (Source: MedicineNet Heart General)
Health Tip: Symptoms of Ketoacidosis
Title: Health Tip: Symptoms of KetoacidosisCategory: Health NewsCreated: 3/12/2010 10:10:00 AMLast Editorial Review: 3/15/2010 (Source: MedicineNet Diabetes General)
Start Metformin Early for Best Results
Title: Start Metformin Early for Best ResultsCategory: Health NewsCreated: 3/12/2010 2:10:00 PMLast Editorial Review: 3/15/2010 (Source: MedicineNet Diabetes General)
2 Drugs Fail to Prevent Diabetes in the Overweight
Title: 2 Drugs Fail to Prevent Diabetes in the OverweightCategory: Health NewsCreated: 3/14/2010 10:10:00 AMLast Editorial Review: 3/15/2010 (Source: MedicineNet Diabetes General)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Intense Cholesterol, Blood Pressure Therapies Don't Help Type 2 Diabetics
Title: Intense Cholesterol, Blood Pressure Therapies Don't Help Type 2 DiabeticsCategory: Health NewsCreated: 3/14/2010 10:10:00 AMLast Editorial Review: 3/15/2010 (Source: MedicineNet Diabetes General)
2 Drugs Fail to Prevent Diabetes in the Overweight
Title: 2 Drugs Fail to Prevent Diabetes in the OverweightCategory: Health NewsCreated: 3/14/2010 10:10:00 AMLast Editorial Review: 3/15/2010 (Source: MedicineNet Senior Health General)
2 Drugs Fail to Prevent Diabetes in the Overweight
Title: 2 Drugs Fail to Prevent Diabetes in the OverweightCategory: Health NewsCreated: 3/14/2010 10:10:00 AMLast Editorial Review: 3/15/2010 (Source: MedicineNet Feet and Fitness General)
Does Cholesterol Really Matter?
(NaturalNews) I'd like to shine the spotlight on one of medicine's sacred cows- the belief that lowering cholesterol with drugs protects against heart attacks and premature death. Our obsession with cholesterol began in the 1950s when studies linked high consumption of animal fat with high rates of heart disease. This opened the door for clinical trials that laid the foundation of a new paradigm: the cholesterol theory of cardiovascular disease.This theory has had profound ramifications. It changed the way we eat (fats bad, carbohydrates good) and contributed to our problems with obesity and diabetes. It wormed its way into "clinical practice guidelines"- cholesterol management has become a "standard of care" that doctors are expected to follow. It spawned the invasive heart surgery indust...
2 Drugs Fail to Prevent Diabetes in the Overweight
Title: 2 Drugs Fail to Prevent Diabetes in the OverweightCategory: Health NewsCreated: 3/14/2010 10:10:00 AMLast Editorial Review: 3/15/2010 (Source: MedicineNet Weight Management General)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Aggressive Treatments Don't Help Diabetes Patients
Lowering blood pressure and blood fat levels to below current targets did not bring down higher risks of heart problems for diabetes patients, according to new results from a landmark federal study. (Source: WebMD Health)
Relation of stressful life events to metabolic control among adolescents with diabetes: 5-year longitudinal study.
Conclusion: Stressful life events are related to poor metabolic control?especially for older adolescents. A primary mechanism appears to be a lack of good self care. (PsycINFO Database Record (c) 2010 APA, all rights reserved) (Source: Health Psychology)
How muscle cells control fatty acid uptake
(Karolinska Institutet) A new study from the Swedish medical university Karolinska Institutet shows that the blood vessels and muscles of the heart can regulate the uptake of fatty acids that we ingest through meat, milk products and other food. The researchers have also identified the way in which regulation is governed by the muscles themselves. The results open the way for new forms of treatment for pathological fat accumulation in the muscles which, in turn, increases the risk of type 2 diabetes and cardiovascular disease. (Source: EurekAlert! - Medicine and Health)
Diabetes Heart Treatments May Cause Harm
Three aggressive treatment strategies doctors had expected would prevent heart attacks among people with Type 2 diabetes and some who are the verge of developing it have proved to be ineffective or even harmful, new studies show. (Source: RWJF News Digest - Quality/Equality)
How muscle cells control fatty acid uptake
A new study shows that the blood vessels and muscles of the heart can regulate the uptake of fatty acids that we ingest through meat, milk products and other food. The researchers have also identified the way in which regulation is governed by the muscles themselves. The results open the way for new forms of treatment for pathological fat accumulation in the muscles which, in turn, increases the risk of type 2 diabetes and cardiovascular disease. (Source: ScienceDaily Headlines)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Study points to potential new drug for type 2 diabetes
(Ohio State University) An experimental oral drug has lowered blood sugar levels and inflammation in mice with Type 2 diabetes, suggesting that the medication could someday be added to the arsenal of drugs used by millions of Americans with this disease, according to new research. (Source: EurekAlert! - Medicine and Health)
Steps to Stop Heart Attacks in Diabetics Fail, Studies Say
Three treatment strategies that doctors had expected would prevent heart attacks among people with Type 2 diabetes have proven to be ineffective or even harmful. (Source: NYT &gt; Health)
ACC: ACCORD Vindicates Patient-Centered Cardiac Care in Diabetes
ATLANTA (MedPage Today) -- Individualized care is again the message in the wake of lipid and hypertension results from the ACCORD trial presented here at the American College of Cardiology meeting, leading cardiologists suggest in this exclusive InFocus&#8482; report. (Source: MedPage Today Cardiovascular)
ACC: Pushing Blood Pressure Too Low May be Harmful (CME/CE)
ATLANTA (MedPage Today) -- Lower is not better for blood pressure control in patients with diabetes and coronary artery disease, a secondary analysis of a randomized trial showed. (Source: MedPage Today Cardiovascular)
Video: Diabetes Treatments Deemed Harmful
A major diabetes study has found that common treatments don't reduce heart trouble and some may actually cause harm. Elaine Quijano speaks with Russ Mitchell about this revealing study. (Source: Health News: CBSNews.com)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Video: Diabetes Treatments Deemed Harmful
A major diabetes study has found that common treatments don't reduce heart trouble and some may actually cause harm. Elaine Quijano speaks with Russ Mitchell about this revealing study. (Source: Health News: CBSNews.com)
No quick fix for diabetes risk
Exercise and diet are key to prevent diabetes in high-risk people, say researchers who found two drug treatments offer no benefit. (Source: BBC News | Health | UK Edition)
ACCORD BP: Intensive BP control does not benefit diabetic patients at high CV risk
Intensive blood pressure control does not reduce the rate of cardiovascular events in patients with Type 2 diabetes and high CV risk, reveals research presented at the 59th Annual Scientific Sessions of the American College of Cardiology in Atlanta, Georgia, USA. (Source: MedWire News - Cardiology)
Valsartan and nateglinide disappoint in diabetes prevention
Adding treatment with the ACE inhibitor valsartan to lifestyle modification modestly reduces progression to diabetes in patients with impaired glucose tolerance and cardiovascular disease or risk factors, whereas the short-acting insulin secretagogue nateglinide has no significant effect, results of the NAVIGATOR trial reveal. (Source: MedWire News - Cardiology)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
ACCORD BP: Intensive BP control does not benefit diabetic patients at high CV risk
Intensive blood pressure control does not reduce the rate of cardiovascular events in patients with Type 2 diabetes and high CV risk, reveals research presented at the 59th Annual Scientific Sessions of the American College of Cardiology in Atlanta, Georgia, USA. (Source: MedWire News - Diabetes)
INVEST analysis challenges diabetic BP targets
Tight control of systolic blood pressure to a target of less than 130 mmHg in diabetics with coronary artery disease does not significantly reduce the incidence of cardiovascular events compared with usual control, and is associated with increased all-cause mortality, shows an analysis of INVEST. (Source: MedWire News - Diabetes)
Valsartan and nateglinide disappoint in diabetes prevention
Adding treatment with the ACE inhibitor valsartan to lifestyle modification modestly reduces progression to diabetes in patients with impaired glucose tolerance and cardiovascular disease or risk factors, whereas the short-acting insulin secretagogue nateglinide has no significant effect, results of the NAVIGATOR trial reveal. (Source: MedWire News - Diabetes)
Good diet and exercise not medication key in IGT
Losing weight most effective in staving off diabetes in high risk groupsRelated items from OnMedicaPrimary care criticised over retinopathy failingsType 2 diabetes - shock toll on South Asian children Middle aged men at highest risk of diabetesGovernment slammed for painting "rosy picture" of diabetes careBenefits of statins far outweigh diabetes risk (Source: OnMedica Latest News)
Direct-to-consumer personal genome testing: ethical and regulatory issues that arise from wanting to 'know' your DNA
Direct-to-consumer personal genome testing (DTC-PGT) screens a customer's genome for the presence of single nucleotide polymorphisms that are reported to be associated with various diseases, disease risk factors and personal characteristics. The range of health risks covered by personal genome testing (PGT) includes cancer, heart disease, obesity, diabetes mellitus and osteoporosis. PGT also detects a range of other characteristics, such as alcohol 'flush reaction', eye colour, ear wax type and bitter taste perception. Information about ancestry and family history is also available. Although DTC-PGT is still a relatively new enterprise, the technology has the potential for rapid expansion as it becomes more accessible to consumers who wish to obtain information about their genetic profile....<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Non-axial bone fracture but not depression as a risk factor for coeliac disease
This study examined the hypothesis that patients taking antidepressants or presenting with fractures could represent new subgroups at higher risk for coeliac disease. A total of 105 and 199 consecutive patients presenting to hospital taking antidepressants and/or with a fracture was screened with IgA tissue transglutaminase and had their IgA serum levels quantified. Patients with positive serology were offered further diagnostic and management follow up. No patients taking antidepressants had positive serology. Seven with fractures had elevated titres of IgA tissue transglutaminase. All of these patients had presented with non-axial fractures, representing a prevalence of 5.2% (95% confidence interval: 1.4[ndash]8.9%). Uptake of further investigation and management was poor. Patients prese...
The relation between different dimensions of alcohol consumption and burden of disease: an overview
Conclusions Overall, these findings indicate that alcohol impacts many disease outcomes causally, both chronic and acute, and injuries. In addition, a pattern of heavy episodic drinking increases risk for some disease and all injury outcomes. Future studies need to address a number of methodological issues, especially the differential role of average volume versus drinking pattern, in order to obtain more accurate risk estimates and to understand more clearly the nature of alcohol[ndash]disease relationships. (Source: Addiction)
Study Finds Too Many Meds Bad for Diabetics
A new landmark federal study reveals more is not always better, when it comes to medications for certain diabetics. The news is disappointing for those with Type II Diabetes, which is the most common form of diabetes. New information released over the... (Source: OrlandoSentinel: Medical Research)
NAVIGATOR study evaluates effect of nateglinide and valsartan on the incidence of diabetes and cardiovascular events
Source: NEJM Area: News The New England Journal of Medicine has featured outcomes of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) study in which nateglinide and valsartan were evaluated for the reduction in risk of diabetes or cardiovascular events, in patients with impaired glucose tolerance. Data on the two drugs have been presented as separate studies. &nbsp; The double-blind trial involved 9306 participants with impaired glucose tolerance and either cardiovascular disease or cardiovascular risk factors, who were randomised in a 2-by-2 factorial design, to receive nateglinide (up to 60 mg three times daily) or placebo, with valsartan (up to 160 mg daily) or placebo, in addition to participation in a lifestyle modification programme. Pati...
Combination lipid lowering not routinely justified in patients with type2 diabetes
Source: NEJM Area: News In high-risk patients with type-2 diabetes, adding a fibrate to simvastatin did not decrease major cardiovascular events compared to simvastatin alone in a major randomised controlled trial. &nbsp; While it is accepted that people with type 2 diabetes are at increased cardiovascular risk compared to those without, and that management of all aspects of cardiovascular risk is important in such people, there is still debate over how best to do this. The ACCORD (Action to Control Cardiovascular Risk in Diabetes) trial investigated two areas of cardiovascular risk management - intensive BP control and combination lipid lowering, as well as intensive vs. standard glycaemic control. All participants in the trial were randomised to one of the two glycaemia management a...<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Intensive BP control in type 2 diabetes doesn't seem to improve outcomes
Source: NEJM Area: News Managing patients with hypertension and type 2 diabetes to a target systolic blood pressure (BP) of less than 120mmHg did not reduce cardiovascular events compared to a target of 140mmHg in a major randomised controlled trial. &nbsp; While it is accepted that people with type 2 diabetes are at increased cardiovascular risk compared to those without, and that management of all aspects of cardiovascular risk is important in such people, there is still debate over how best to do this. The ACCORD (Action to Control Cardiovascular Risk in Diabetes) trial investigated two areas of cardiovascular risk management - intensive BP control and combination lipid lowering, as well as intensive vs. standard glycaemic control. All participants in the trial were randomised to o...
ACC: Valsartan, Nateglinide Do Not Reduce Cardio Events
In patients with impaired glucose tolerance and cardiovascular disease or cardiovascular risk factors, neither valsartan nor nateglinide reduces the incidence of cardiovascular outcome measures, but valsartan does lead to a modest reduction in the incidence of diabetes, according to the results of two analyses from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research study group published online March 14 in the New England Journal of Medicine to coincide with the Annual Scientific Session of the American College of Cardiology, held from March 14 to 16 in Atlanta. (Source: Modern Medicine)
Effects of Hemoglobin-Based Oxygen Carriers Studied
Vasoconstrictor side effects of a hemoglobin-based oxygen carrier are not improved with reduction of low molecular weight hemoglobin concentrations to less than 1 percent, and are worse in animals with reduced nitric oxide levels associated with endothelial dysfunction due to diabetes or a high-fat diet, according to a study in the March issue of Anesthesiology. The findings give new insights into how to better understand and utilize these hemoglobin-based oxygen carriers, otherwise known as artificial blood. (Source: Modern Medicine)
ACC: Two Type 2 Diabetes Approaches Don't Help Heart
In type 2 diabetes patients at high risk for cardiovascular events, combination lipid therapy with fenofibrate and simvastatin does not reduce the rate of cardiovascular events compared with simvastatin alone, and intensive blood pressure control, compared to standard blood pressure control, also does not reduce the rate of adverse cardiovascular events, according to the results of two analyses of the Action to Control Cardiovascular Risk in Diabetes study published online March 14 in the New England Journal of Medicine to coincide with the Annual Scientific Session of the American College of Cardiology, held from March 14 to 16 in Atlanta. (Source: Modern Medicine)
Severe hypertriglyceridemia linked with excess CHD, stroke mortality
Severe hypertriglyceridemia is associated with a markedly increased risk for coronary heart disease and stroke mortality, even in the absence of diabetes, a UK study shows. (Source: MedWire News - Lipidology)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Impact of integrin-matrix interaction and signaling on insulin gene expression and the mesenchymal transition of human [beta]-cells
A critical shortage of donor pancreata currently prevents the development of a universal cell-based therapy for type I diabetes. The ex vivo expansion of insulin-producing [beta]-cells offers a potential solution but is problematic due to the inherent tendency of these cells to transition into mesenchymal-like cells that are devoid of function. Here, we demonstrate for the first time that exposure to elements of the extracellular matrix (ECM) directly potentiates the mesenchymal transition of cultured fetal [beta]-cells and causes associated declines in insulin gene expression. Individual ECM constituents varied in their ability to induce such responses, with collagen-IV (C-IV) and fibronectin inducing strong responses, whereas laminin-1 had no significant effect. Mesenchymal transition an...
Bipolar Disorder, Meds and Blood Sugar
I gained 80 pounds on various psychiatric meds, and I know hundreds of our community members are in the same boat. And along with the weight gain came the usual problems - high blood pressure and high cholesterol, not to mention the misery of being fat for the first time in my life. And now there's another problem related to that weight gain: high blood sugar, or hyperglycemia. As we reported last year, there are many lawsuits claiming that Seroquel causes diabetes, but the courts haven't bought the argument yet. And although I'm now borderline diabetic, I can't claim that, either, since I have a strong family history of diabetes. Still, the fact remains that my blood sugar is now high enough that I have to take medication for it. And bipolar disorder itself has a possible connection to ...
Search for Diabetes Therapy Falls Short
New strategies to prevent and treat diabetes and heart disease failed to improve care in two major studies, frustrating researchers' efforts to find more-effective approaches to the world's burgeoning diabetes epidemic. (Source: WSJ.com: Health)
Blood Pressure Drugs No Help for Diabetes
Studies: Statins, Fibrates to Lower Fats, Cholesterol and Blood Pressure Do Not Reduce Heart Attack Risk in Diabetics (Source: Health News: CBSNews.com)
miR-375 enhances palmitate-induced lipoapoptosis in insulin-secreting NIT-1 cells by repressing myotrophin (V1) protein expression.
Authors: Li Y, Xu X, Liang Y, Liu S, Xiao H, Li F, Cheng H, Fu Z Lipoapoptosis of pancreatic beta cells caused by elevated circulating free fatty acids (FFAs) has now been recognized to be a pivotal factor contributing to beta cellular dysfunction and beta-mass lose in type 2 diabetes. Although recent studies suggested an important role for the ceramide pathway in the late destructive phase of lipid overload in the pancreatic beta cells, the overall underlying mechanisms leading to lipoapoptosis, however, remained poorly understood. mir-375 was recently characterized to be a pancreatic islet-specific miRNA implicated in the regulation of insulin secretion and beta-mass turnover. In the present study we further examined its effect on palmitate-induced lipoapoptosis in NIT-1 cells, a NOD...<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
ACC: FDA Announces Review of ACCORD Data
ATLANTA (MedPage Today) -- The FDA said it will conduct a full review of findings from a study which concluded that neither aggressive lipid-lowering therapy nor tight blood pressure control reduced cardiovascular events in persons with diabetes. (Source: MedPage Today Cardiovascular)
Diabetes Heart Treatments May Do Harm
Three treatment strategies that doctors had expected would prevent heart attacks among people with Type 2 diabetes have proven to be ineffective or even harmful. (Source: NYT &gt; Health)
Novartis drugs fail to help high-risk patients
ATLANTA (Reuters) - The Novartis diabetes drug Starlix failed to reduce progression to the disease or cut down on serious heart problems in patients at high risk for both diabetes and heart disease, according to a large study released on Sunday. (Source: Reuters: Health)
2 Drugs Fail to Prevent Diabetes in the Overweight
Diovan, Starlix also had limited or no effect in shielding users from cardiovascular woes, study finds Source: HealthDay Related MedlinePlus Pages: Diabetes, Heart Diseases--Prevention, Obesity (Source: MedlinePlus Health News)
Intense Cholesterol, Blood Pressure Therapies Don't Help Type 2 Diabetics
Study findings underscore the importance of exercise and proper nutrition, expert says Source: HealthDay Related MedlinePlus Pages: Cholesterol, Diabetes, High Blood Pressure (Source: MedlinePlus Health News)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
Correlates of Upper Extremity Disability in Medical Transcriptionists
Conclusions Prior upper extremity musculoskeletal symptoms requiring treatment or ergonomic assessment, high perceived stress and a history of smoking are associated with self-reported disability. Diabetics have significantly higher levels of upper extremity disability than non-diabetics. Prospective studies are needed to see if interventions addressing these factors will prevent future work disability. Content Type Journal ArticleDOI 10.1007/s10926-010-9235-7Authors Russell Gelfman, College of Medicine, Mayo Clinic Department of Physical Medicine and Rehabilitation 200 First Street SW Rochester MN 55905 USATimothy J. Beebe, College of Medicine, Mayo Clinic Health Sciences Research 200 First Street SW Rochester MN 55905 USAPeter C. Amadio, College of Medicine, Mayo Clinic Departm...
Long-term prognosis in ethnic Chinese patients with unprotected left main coronary artery disease
Conclusion&nbsp;&nbsp;For Chinese patients with unprotected left main coronary artery disease, a significant higher risk of cardiovascular death was noted in the medical therapy group. Overall the long-term cardiovascular survival was similar in LMCA patients treated with either PCI or CABG, but CABG provided better survival outcome in high-risk subgroup patients. Content Type Journal ArticleCategory Original PaperDOI 10.1007/s00392-010-0139-5Authors Hui-Chun Huang, National Taiwan University Hospital, National Taiwan University College of Medicine Division of Cardiology, Department of Internal Medicine, Graduate Institute of Clinical Medicine No. 7 Chung-Shan South Road Taipei 100 TaiwanHsien-Li Kao, National Taiwan University Hospital, National Taiwan University College of M...
No heart benefit seen with fibrates in diabetics
ATLANTA (Reuters) - Adding a triglyceride lowering drug to cholesterol fighting statins provided no additional protection from heart attack, stroke and death from heart disease in patients with Type 2 diabetes, according to data from a large study. (Source: Reuters: Health)
NAVIGATOR Off Course to Diabetes Prevention With Valsartan, Nateglinide
In a population with impaired glucose tolerance and CV disease or risk factors, the angiotensin receptor blocker had a slight effect and the short-acting insulin secretagogue had no favorable impact on progression to diabetes; neither drug prevented cardiovascular events. Heartwire (Source: Medscape Today Headlines)
ACCORD: Fenofibrate No Benefit to Statin Therapy in High-Risk Diabetic Patients
The findings do not support the use of combination fibrate-statin therapy to reduce cardiovascular risk in the majority of patients with type 2 diabetes who are at high risk for cardiovascular disease, according to the ACCORD investigators. Heartwire (Source: Medscape Today Headlines)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Get the very latest Swine Flu news via the MedWorm <b><a href="http://www.medworm.com/rss/search.php?qu=%2Bswine+%2B%28influenza+flu%29&t=Swine+Flu&f=infectiousdiseases&r=Any&o=d" target ="_self">Swine Flu RSS news feed</a></b> - updated hourly from thousands of authoritative health and news sources.</p></div>
ACC: Close Lipid and BP Control Fail in Diabetes (CME/CE)
ATLANTA (MedPage Today) -- Intensive blood pressure and lipid management does little against elevated cardiovascular risk in diabetes, according to results from the ACCORD study, again proving lower isn't always better. (Source: MedPage Today Cardiovascular)
ACCORD: Fenofibrate no benefit to statin therapy in high-risk diabetic patients
The findings do not support the use of combination fibrate-statin therapy to reduce cardiovascular risk in the majority of patients with type 2 diabetes who are at high risk for cardiovascular... For complete story visit theheart.org. (Source: theHeart.org)
NAVIGATOR off course to diabetes prevention with valsartan, nateglinide
In a population with impaired glucose tolerance and CV disease or risk factors, the angiotensin receptor blocker had a slight effect and the short-acting insulin secretagogue had no favorable impact... For complete story visit theheart.org. (Source: theHeart.org)
Clinical features of Escherichia coli pneumonia
Abstract&nbsp;&nbsp; Escherichia coli pneumonia was clinically reviewed. Twenty-two patients with E. coli pneumonia were admitted for treatment to Kawasaki Medical School Kawasaki Hospital, between January 2006 and December 2008. Clinical features were retrospectively reviewed. Results showed that: (1) hospital-acquired pneumonia occurred in elderly patients with underlying diseases, such as cerebrovascular disease, diabetes mellitus, or chronic obstructive pulmonary disease; (2) more patients had complications of urinary-tract infection or alimentary infection due to E. coli; (3) previous administration of antibacterial agents did not become a risk factor; (4) resistance to ampicillin (ABPC) and levofloxacin (LVFX) was observed; and (5) mortality was 22.7%. Content Type Journal ...

not be helpful and could even be dangerous.

The Type Two info provided here is up to date. It is backed by scientific research and applies not only to people who have been diagnosed with type II diabetes, but also to people who have “pre-diabetes”, insulin resistance or a family history of the condition.

Type 2 is sometimes referred to as adult-onset, maturity-onset or non-insulin dependent diabetes. This condition is different from Type 1, insulin dependent, childhood or juvenile in several ways. First, there are no known preventative measures for Type 1, but Type 2 may be preventable.

In type 1 diabetes, the body does not produce insulin, a hormone that allows glucose to enter and energize the cells. Without insulin, the glucose is “stuck” in the blood stream and cannot be used by the cells.

In type 2 diabetes, the body produces less than normal amounts of insulin and the insulin that is produced is not used properly. Failure of the body to recognize and properly use insulin is referred to as insulin resistance.

According to the type two info, facts and figures provided by national health organizations, of the 20.8 million people in the United States who have been diagnosed with diabetes, 90-95% have type 2. Another 54 million have pre-diabetes.

In pre-diabetes, blood glucose levels are higher than normal, but not high enough to be diagnosed as type 2. Without preventative measures, pre-diabetes can eventually lead to type II.

The recently completed Prevention Program showed conclusively that changes in diet and increasing physical activity can prevent pre-diabetes from becoming type 2 diabetes. This study is one reason that many people look for type 2 diet info. It is important to be able to distinguish the fad diets from the healthy diets. The American Association is currently working to create more materials to help people understand the difference.

There is one simple way to tell the difference between a fad diet and a healthy diet. A healthy diet is one that you could follow for the rest of your life, without concern about nutritional deficiencies. A healthy diet provides adequate intakes of fat, carbohydrates and protein. Some of the latest type 2 diet info promotes a “low-carb” diet. The American Association has this to say:

“The long-term effects of diets high in protein and low in carbohydrate are unknown. Although such diets may produce short-term weight loss and improved glycemia, it has not been established that weight loss is maintained long-term. The long-term effect of such diets on plasma LDL cholesterol is also a concern.”

The general expert consensus is that in a healthy daily diet 40% of calories should come from carbohydrates, 30% from protein and 30% from fat. You can safely reduce carbs to 35% and increase protein to 35%, but to avoid weight gain and increase in LDL cholesterol, 30% fat is enough.

Smith Chen is an author and internet marketing consultant.
Find more about Health Tips and review page more